We hypothesised that studying lymphocytes with focus on Tregs, proliferating CD4+ and CD8+ T cells in two compartments (blood and lung), at sarcoidosis diagnosis and in follow-up studies, may provide mechanistic clues to clinical phenotype differences, and offer valuable information that could make decisions on treatment better founded. This evidence concerns the gene CD8A and sarcoidosis.